Barclays Maintains an 'Equalweight' on Hanesbrands (HBI); Q1 Preview
Tweet
Share
E-mailGet Alerts HBI Hot Sheet
Price: $6.47 --0%
Rating Summary:
9 Buy, 15 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 21 | New: 20
Rating Summary:
9 Buy, 15 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 21 | New: 20
Join SI Premium – FREE
Barclays maintains an 'Equalweight' on Hanesbrands (NYSE: HBI) price target of $35.00.
Analyst Robert S. Drbul sees a Q1 loss of $0.30 and maintains FY12 EPS at $2.50. Drbul sees a Q1 revenue decline of 3.3% to $1.00 billion. The Barclays analyst believes Q1 estimates are achievable given the conservative assumptions.
As for outlook, Drbul, said, "On the call, we expect the company to address 1) updates to cotton costs for FY12; 2) pricing strategies at retail given lower input costs; and 3) progress on de-risking of the Imagewear business and impact of this initiative to revenue and EPS."
For an analyst ratings summary and ratings history on Hanesbrands click here. For more ratings news on Hanesbrands click here.
Shares of Hanesbrands closed at $27.41 yesterday.
Analyst Robert S. Drbul sees a Q1 loss of $0.30 and maintains FY12 EPS at $2.50. Drbul sees a Q1 revenue decline of 3.3% to $1.00 billion. The Barclays analyst believes Q1 estimates are achievable given the conservative assumptions.
As for outlook, Drbul, said, "On the call, we expect the company to address 1) updates to cotton costs for FY12; 2) pricing strategies at retail given lower input costs; and 3) progress on de-risking of the Imagewear business and impact of this initiative to revenue and EPS."
For an analyst ratings summary and ratings history on Hanesbrands click here. For more ratings news on Hanesbrands click here.
Shares of Hanesbrands closed at $27.41 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Freedom Broker Upgrades PrimeEnergy Resource (PNRG) to Hold
- JPMorgan Upgrades Hyundai Marine and Fire Insurance (001450:KS) to Neutral
- Benchmark Reiterates Speculative Buy Rating on Milestone Scientific (MLSS)
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS ViewRelated Entities
BarclaysSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
